| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,520 | $30 | $91.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 7,740 | $10 | $85.1K |
| J0897 | Injection, denosumab, 1 mg | 2,460 | $20 | $44.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 330 | $90 | $29K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 210 | $40 | $9.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 90 | $90 | $8.2K |
| J3489 | Injection, zoledronic acid, 1 mg | 430 | $10 | $2.5K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 20 | $170 | $2.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 20 | $130 | $2.5K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 90 | $20 | $1.8K |